Skip to main content
. 2007 Sep 26;81(23):12758–12765. doi: 10.1128/JVI.01145-07

TABLE 1.

Strains used in the complete genome alignment and phylogenetic analysis

VZV straina Genotype by the indicated method:b
Diseasec Year isolated Location Dominant regiond Accession no.e
1 2 3
Dumas E1 C A V 1970s The Netherlands Europe, North America, Australia XO4370
BC E1 C A Z 1999 Canada AY548171
MSP E1 C A V 1995 United States AY548170
SD E1 C A NA 1980 United States DQ479953
KEL E1 C A Z 2002 United States DQ479954
36 E1 C A V 1998 Canada DQ479958
49 E1 C A V 1999 Canada DQ479959
32 P5 E1 C A V 1976 United States DQ479961
32 P22 E1 C A NA DQ479962
Russia E1 C A Z Russia NA
NH293 E1 C A V 2000 United States DQ674250
HJO E2 B D Z 1990s Germany Not dominant in any region AJ871403
11 E2 B D Z 1996 Canada DQ479955
22 E2 B D Z 1998 Canada DQ479956
03-500 E2 B D NA 2003 Canada DQ479957
CA123 M1 A V 1990s United States Central Africa DQ457052
DR M2 J1 C Z United States Indochina DQ452050
8 M2 J1 C Z 1995 Canada DQ479960
pOkaf J J1 B V 1970 Japan Japan AB097933
vOka AB097932
VarilRix DQ008354
VariVax DQ008355
a

Strains are grouped with reference strains (in boldface).

b

See text for a description of methods 1, 2, and 3.

c

V, varicella; Z, zoster; NA, disease condition of isolate is not available.

d

In the region(s), >50% of isolates are of the indicated genotype(s).

e

NA, not available.

f

vOka (Biken), VarilRix, and VariVax are all preparations of attenuated VZV derived from strain pOka.